Trials / Completed
CompletedNCT02715635
Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation
A Double-blind, Randomised, Placebo-controlled Parallel Study to Investigate the Effect of Dietary Nitrate on a Model of Vascular Dysfunction in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Queen Mary University of London · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The principal research objective is to determine whether inorganic nitrate in the form of beetroot juice compared to placebo control prevents the systemic inflammation that underlies typhoid vaccine-induced endothelial dysfunction
Detailed description
We wish to determine in a prospective manner whether inorganic nitrate affects the endothelial dysfunction induced by systemic inflammation. At baseline we will measure flow-mediated dilatation (FMD) and peripheral augmentation index, as well as aortic stiffness, as measured by pulse wave velocity (PWV). Volunteers will then receive \~8 mmols of dietary nitrate or nitrate free placebo juice once daily for 6 days. After this, depending on availability, volunteers will receive a typhoid vaccine Typherix®, GlaxoSmithKline UK or Typhim Vi ™, AAH Pharmaceuticals Ltd). This vaccine generates a mild systemic inflammation that is associated with vascular dysfunction. All vascular function measures will be repeated at 8 hours and 32 hours after vaccine administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Typhoid vaccine | The typhoid vaccine is composed of purified polysaccharide from S. typhi capsule 25 micrograms contained in 0.5 ml solution |
| DIETARY_SUPPLEMENT | Concentrate beetroot Juice | 140 ml containing \~8 mmol of inorganic nitrate |
| DIETARY_SUPPLEMENT | Concentrate beetroot Juice (Placebo) | 140 ml which is nitrate-depleted |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2020-12-01
- Completion
- 2021-08-01
- First posted
- 2016-03-22
- Last updated
- 2022-07-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02715635. Inclusion in this directory is not an endorsement.